Icon

CUVPOSA (nda022571)- (1MG/5ML)

GLYCOPYRROLATE MERZ PHARMS
1MG/5ML
Yes No
2023-Aug-20 Expired
2017-Jul-28 2013-Jul-28
None No
CUVPOSA is an anticholinergic indicated to reduce chronic severe drooling in patients aged 3-16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy).
3 0 3
Total Other Developers 13
Drugs with Suitability No
1MG/5ML ** ** Up - 3
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ***** *************** ******* *** *********** **** ***. *** ** ***, *** ************, **********, ********* ******, ***** (***) ***
****** ***** ****** ***** *************** ******* *********** **** ***. *** ** ***, *** ************, **********, ********* ******, ***** (***) ***
****** ****** ****** ****** ****** ******* ******* *********** ****** **. ***, ******* *******, *********** ******,, **********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.